TY - JOUR
T1 - Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naja kaouthia cobra venom
AU - Hamako, Jiharu
AU - Matsui, Taei
AU - Nishida, Sachiyo
AU - Nomura, Shosaku
AU - Fujimura, Yoshihiro
AU - Ito, Masayuki
AU - Ozeki, Yasuhiro
AU - Titani, Koiti
PY - 1998/9
Y1 - 1998/9
N2 - A von Willebrand factor (vWF)-binding and -cleaving metalloproteinase, termed 'kaouthiagin', was purified from the venom of cobra snake Naja kaouthia. Kaouthiagin is a monomer with a molecular mass of about 46 kDa and 51 kDa under non-reducing and reducing conditions, respectively, and the N-terminal amino acid sequence is homologous to high molecular mass snake venom metalloproteinases. Kaouthiagin bound to vWF in a divalent ion-independent manner, but the reduced kaouthiagin failed to interact with vWF, suggesting that the protein conformation maintained by intrachaindisulfide linkages of the molecule is essential for the binding to vWF. Neither botrocetin nor bitiscetin, vWF-binding modulators from another snake venom, interfered with the binding between kaouthiagin and vWF, but a monoclonal antibody VW92-3 specific to the N-terminal region of vWF (residues 1-910) inhibited the binding. Without affecting platelet GPIb/IX and GPIIb/IIIa, kaouthiagin specifically cleaved vWF between residues Pro-708 and Asp-709 in a divalent ion-dependent manner to diminish the multimeric structure of vWF in plasma, resulting in the loss of ristocetin-induced platelet aggregability and the collagen-binding activity of vWF. These results indicate that kaouthiagin is a unique metalloproteinase which specifically binds to and cleaves vWF at a specific site and that it will be a useful tool for functional dissection of vWF.
AB - A von Willebrand factor (vWF)-binding and -cleaving metalloproteinase, termed 'kaouthiagin', was purified from the venom of cobra snake Naja kaouthia. Kaouthiagin is a monomer with a molecular mass of about 46 kDa and 51 kDa under non-reducing and reducing conditions, respectively, and the N-terminal amino acid sequence is homologous to high molecular mass snake venom metalloproteinases. Kaouthiagin bound to vWF in a divalent ion-independent manner, but the reduced kaouthiagin failed to interact with vWF, suggesting that the protein conformation maintained by intrachaindisulfide linkages of the molecule is essential for the binding to vWF. Neither botrocetin nor bitiscetin, vWF-binding modulators from another snake venom, interfered with the binding between kaouthiagin and vWF, but a monoclonal antibody VW92-3 specific to the N-terminal region of vWF (residues 1-910) inhibited the binding. Without affecting platelet GPIb/IX and GPIIb/IIIa, kaouthiagin specifically cleaved vWF between residues Pro-708 and Asp-709 in a divalent ion-dependent manner to diminish the multimeric structure of vWF in plasma, resulting in the loss of ristocetin-induced platelet aggregability and the collagen-binding activity of vWF. These results indicate that kaouthiagin is a unique metalloproteinase which specifically binds to and cleaves vWF at a specific site and that it will be a useful tool for functional dissection of vWF.
UR - http://www.scopus.com/inward/record.url?scp=0031787654&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031787654&partnerID=8YFLogxK
U2 - 10.1055/s-0037-1615236
DO - 10.1055/s-0037-1615236
M3 - Article
C2 - 9759634
AN - SCOPUS:0031787654
SN - 0340-6245
VL - 80
SP - 499
EP - 505
JO - Thrombosis and Haemostasis
JF - Thrombosis and Haemostasis
IS - 3
ER -